A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815
ML Belladonna, MC Fioretti, R Bianchi… - International journal of …, 1996 - Elsevier
Highly immunogenic (“xenogenized”) tumour variants appear after treatment of murine
mastocytoma P815 with the triazene derivative DTIC, a phenomenon associated with the …
mastocytoma P815 with the triazene derivative DTIC, a phenomenon associated with the …
Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity
N Mador, H Falk, M Bergel, A Panet… - Cancer Immunology …, 1997 - Springer
We have previously developed an experimental model for the xenogenization of malignant
lymphoma. From highly tumorigenic S49 mouse lymphoma cells that proliferate in …
lymphoma. From highly tumorigenic S49 mouse lymphoma cells that proliferate in …
Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia
S Ben-Efraim, B Bizzini, EH Relyveld - Biomedicine & pharmacotherapy, 2000 - Elsevier
The need to modify tumor cells in order to render them more “immunogenic” was based on
the assumption that normal, nonmodified tumor cells are non or weakly immunogenic and as …
the assumption that normal, nonmodified tumor cells are non or weakly immunogenic and as …
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells
Previously tumorigenic P815 tumor cells are rejected by histocompatible mice after
transfection with a mutated retroviral gene, and the host is made resistant to subsequent …
transfection with a mutated retroviral gene, and the host is made resistant to subsequent …